Tag: Dallas Talcum Powder lawyer

Talcum Powder Lawyers Win | Talc Lawsuit Alert

Talcum Powder Lawyers Win For Ovarian Cancer Victim

J&J  Has Been Ordered to Pay $417 Million

(Reuters) – A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company’s talc-based products like Johnson’s Baby Powder for feminine hygiene.
The Los Angeles Superior Court jury’s verdict in favor of California resident Eva Echeverria was the largest yet in lawsuits alleging J&J failed to adequately warn consumers about the cancer risks of its talc-based products.
“We are grateful for the jury’s verdict on this matter and that Eva Echeverria was able to have her day in court,” Mark Robinson, her lawyer, said in a statement.
The verdict included $70 million in compensatory damages and $347 million in punitive damages. It was a major setback for J&J, which faces 4,800 similar claims nationally and has been hit with over $300 million in verdicts by juries in Missouri.
“We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder,” J&J said.
Echeverria’s lawsuit was the first out of hundreds of California talc cases to go to trial.
The 63-year-old claimed she developed terminal ovarian cancer after decades of using J&J’s products. Her lawyers argued J&J encouraged women to use its products despite knowing of studies linking ovarian cancer to genital talc use.
J&J’s lawyers countered that studies and federal agencies have not found that talc products are carcinogenic.
The trial follows five prior ones in Missouri state court, where many lawsuits are pending.
J&J lost four of those trials and, along with a talc supplier, has been hit with $307 million in verdicts. Before Monday, the largest verdict was for $110 million.
The Missouri cases, which have largely been brought by out-of-state plaintiffs, have faced jurisdictional questions after the U.S. Supreme Court issued a ruling in June that limited where personal injury lawsuits can be filed.
In a decision in a case involving Bristol-Myers Squibb Co, the Supreme Court said state courts cannot hear claims against companies that are not based in the state when the alleged injuries did not occur there.
The ruling prompted a St. Louis judge, at New Jersey-based J&J’s urging, to declare a mistrial in the talc case already underway.
The judge has nonetheless left the door open for the plaintiffs to argue they still have jurisdiction based on a Missouri-based bottler J&J used to package its products.
The case is Echeverria et al v. Johnson & Johnson, Los Angeles Superior Court, No. BC628228.
(Reporting by Nate Raymond in Boston; Editing by Matthew Lewis and Paul Simao)

If you or a loved one used  Johnson and Johnson Talcum Powder  products for over five years on or near the genital area and now have a diagnosis of ovarian cancer or fallopian tube cancer contact The Talcum Powder Lawyer Helpline today.

Talcum Powder Cancer Lawsuits Continue

Johnson and Johnson Facing Potentially  1000’s Of Ovarian Cancer Lawsuits

Johnson and Johnson won a  fourth talcum powder lawsuit but, had  three judgements of $72 million, $70 million and $55 million. Our lawyers have filed dozens of talcum powder lawsuits  on behalf of women who claim they got  ovarian cancer from Johnson & Johnson’s talcum based powders. A fifth talcum baby powder lawsuit was heard in the 22nd Circuit Court in St. Louis, Missouri, on April 10th. The jury heard the case of Lois Slemp, who alleges that she developed ovarian cancer as a result of long term use of talc powder found in feminine hygiene products made by Johnson & Johnson (J&J).

A California state court judge will convene a 5-day “Sargon” hearing, California’s equivalent of a Daubert proceeding, to determine the admissibility of expert witness testimony. This could be as significant as a trial itself, after a New Jersey state court judge in October nixed testimony from two key expert witnesses for the plaintiff, scuttling what was set to the first talcum powder trial in the state. That decision remains on appeal.

Depending on the outcome of the June hearing, a bellwether trial is scheduled for July in Los Angeles, along with another trial scheduled that same month in Washington D.C. Superior Court. .

The case is captioned Valerie Swann, et al. v. Johnson & Johnson, et al. case number 1422 CC09326-01 in Missouri’s 22nd Judicial Circuit Court.

Talcum powder cases continue in Federal court. About 134 cases are on file in the District of New Jersey Federal Court. The parties have been discussing various topics, including a protective order, a preservation order and other legal issues. A preservation order is where a plaintiff has to store physical or biological evidence for use in trials.

Johnson & Johnson reported in a recent filing with the U.S. Securities & Exchange Commission (SEC) that it has been named a defendant in at least 3,100 product liability claims. These lawsuits are claims by women that Baby Powder and Shower-to-Shower talc-based powders contributed to them getting ovarian cancer.

If you think you have a diagnosis of ovarian cancer due to your use of Baby Powder or Shower To Shower contact us today

 

Talcum Powder- Ovarian Cancer Helpline

The Talcum Powder Lawsuit Helpline has Talcum Powder lawyers filing Talcum Powder lawsuits for women who have gotten ovarian cancer from Talcum Powder. The Talcum Powder Lawsuit Helpline continues to report any recent news regarding the lawsuits and research regarding ovarian cancer. Ovarian cancer is a serious and often fatal disease and we are constantly on the look out for new and important updates that may be of interest to our followers.

We found this article and thought it might be helpful to women. This article discusses some ways to make it easier to find out if you have or are at risk for ovarian cancer.

Testing the  DNA  of a woman should identify the most effective drugs and finds out if other family members are at risk.

Fewer than a third of patients are currently tested, but the team at the Institute of Cancer Research (ICR) in London made it easier for women and increased uptake to 100%.

Experts said the findings were an important step.

The focus of testing is a set of genetic mutations which run in families called BRCA – they cause 15% of the 7,100 ovarian cancers detected in the UK each year.

Knowing if the patient is in the 15% helps improve treatment as some chemotherapy drugs are more effective against tumours caused by BRCA mutations.

And cancer drugs such as PARP inhibitors work only in women with BRCA mutations.

A tumour that is positive for BRCA is also an early warning to other family members that they may be at risk of developing ovarian, breast or prostate cancers.

‘Excellent example’
Testing currently involves getting an appointment with a separate genetics team after being diagnosed by a cancer doctor. The average wait is 12-15 weeks, the researchers say, and only a minority of women go for it.

The ICR team used advances in genetics testing – which is getting faster and cheaper – to offer screening with the original cancer doctor.

Prof Nazneen Rahman, who led the trial, told the BBC News website: “It cuts off all that time on a waiting list and extra consultation. The feedback from patients has been overwhelmingly positive.”

The results of the trial, published in the journal Scientific Reports, showed all patients had screening and got their results in a quarter of the time. It also estimated the National Health Service would save £2.6m a year if it changed the way testing was offered.

Prof Rahman added: “There would be 283 fewer cancers and 77 fewer deaths a year – it really does save lives and money.

“It’s very unusual to get a win-win all round that allows us to help more people but doesn’t cost more.”

It is likely the approach would also work for other cancers, such as those in the breast.

Prof Paul Workman, the chief executive of ICR, said: “Twenty years ago the BRCA2 gene was identified at the ICR. This study is an excellent example of how science such as this can be turned into something very practical that can improve the patient care and save lives. We hope the new model for genetic testing will be rolled out across the NHS.”

Alexandra Holden, from the charity Target Ovarian Cancer, commented: “Any improved access to genetic testing for all women with ovarian cancer is an important step.

“It is essential that all women with ovarian cancer get genetic counseling, as we know from the women with ovarian cancer we support that there can be numerous, complex implications of a test, for all the family.”

Talcum Powder Ovarian Cancer Alert- Reaching Out to America’s Largest Cities

The Talcum Powder Lawsuit Helpline has increased marketing to the largest cities  in the U.S ( NYC,  Los Angeles, CA;  Chicago, IL ; Houston, TX; Philadelphia, PA ; Phoenix,  AZ; San Antonio, TX; San Diego, CA; Dallas, TX;  and San Jose, CA to alert women of  the connection between Talcum Powder products, like Johnson and Johnson’s Baby Powder and Shower to Shower, and ovarian cancer. Women used these products for years around genital areas and on sanitary napkins without knowing that the talc  particles can travel to the ovaries. They can sit there for years causing irritation and inflammation and result in the fatal ovarian cancer diagnosis.

In a recent Talcum Powder lawsuit a jury decided that  Talcum Powder did cause ovarian cancer and awarded $72 million. Manufacturers knew for years and never warned women. Instead they promoted their products for use to stay dry.

The link between ovarian cancer and Talcum Powder ” dusting ”  has been argued  for years. In an article published in the 1971 issue of the British Journal of Obstetrics and Gynecology, it was noted that  research found talcum powder particles inside  ovarian cancer victims. In 2013 Cancer Prevention Research reported that women who used talcum powder faced a 2o%-30% increased risk of ovarian cancer.  Again, this study showed that talc particles can remain embedded in ovaries for up to eight years.

Talcum powder cancer  is  difficult to  of diagnose   in early stages because it can take so many years for the cancer to develop. Studies have shown a clear connection between talcum powder and and a heightened risk of ovarian cancer.

Tje Manufacturers offer not warning for women. Talcum Powder Lawsuit Helpline wants women to know that using Talc based products on the genital area can potentially lead to ovarian cancer. We fell you should be warned.

 

 

NYC tsal